Literature DB >> 26933390

Present status of Accelerator-Based BNCT.

Andres Juan Kreiner1, Javier Bergueiro2, Daniel Cartelli1, Matias Baldo2, Walter Castell2, Javier Gomez Asoia2, Javier Padulo2, Juan Carlos Suárez Sandín2, Marcelo Igarzabal2, Julian Erhardt2, Daniel Mercuri2, Alejandro A Valda3, Daniel M Minsky1, Mario E Debray3, Hector R Somacal3, María Eugenia Capoulat1, María S Herrera1, Mariela F Del Grosso4, Leonardo Gagetti1, Manuel Suarez Anzorena2, Nicolas Canepa2, Nicolas Real2, Marcelo Gun5, Hernán Tacca5.   

Abstract

AIM: This work aims at giving an updated report of the worldwide status of Accelerator-Based BNCT (AB-BNCT).
BACKGROUND: There is a generalized perception that the availability of accelerators installed in hospitals, as neutron sources, may be crucial for the advancement of BNCT. Accordingly, in recent years a significant effort has started to develop such machines.
MATERIALS AND METHODS: A variety of possible charged-particle induced nuclear reactions and the characteristics of the resulting neutron spectra are discussed along with the worldwide activity in suitable accelerator development.
RESULTS: Endothermic (7)Li(p,n)(7)Be and (9)Be(p,n)(9)B and exothermic (9)Be(d,n)(10)B are compared. In addition to having much better thermo-mechanical properties than Li, Be as a target leads to stable products. This is a significant advantage for a hospital-based facility. (9)Be(p,n)(9)B needs at least 4-5 MeV bombarding energy to have a sufficient yield, while (9)Be(d,n)(10)B can be utilized at about 1.4 MeV, implying the smallest possible accelerator. This reaction operating with a thin target can produce a sufficiently soft spectrum to be viable for AB-BNCT. The machines considered are electrostatic single ended or tandem accelerators or radiofrequency quadrupoles plus drift tube Linacs.
CONCLUSIONS: (7)Li(p,n)(7)Be provides one of the best solutions for the production of epithermal neutron beams for deep-seated tumors. However, a Li-based target poses significant technological challenges. Hence, Be has been considered as an alternative target, both in combination with (p,n) and (d,n) reactions. (9)Be(d,n)(10)B at 1.4 MeV, with a thin target has been shown to be a realistic option for the treatment of deep-seated lesions.

Entities:  

Keywords:  Accelerator-Based BNCT; Different nuclear reactions and accelerator types; Worldwide activity

Year:  2014        PMID: 26933390      PMCID: PMC4747659          DOI: 10.1016/j.rpor.2014.11.004

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  15 in total

1.  Measurements of low-energy (d,n) reactions for BNCT. Boron Neutron Capture Therapy.

Authors:  N Colonna; L Beaulieu; L Phair; G J Wozniak; L G Moretto; W T Chu; B A Ludewigt
Journal:  Med Phys       Date:  1999-05       Impact factor: 4.071

2.  Applicability of the 9Be(d,n)10B reaction to AB-BNCT skin and deep tumor treatment.

Authors:  M E Capoulat; D M Minsky; A J Kreiner
Journal:  Appl Radiat Isot       Date:  2011-02-15       Impact factor: 1.513

3.  Development of a Tandem-Electrostatic-Quadrupole facility for Accelerator-Based Boron Neutron Capture Therapy.

Authors:  A J Kreiner; W Castell; H Di Paolo; M Baldo; J Bergueiro; A A Burlon; D Cartelli; V Thatar Vento; J M Kesque; J Erhardt; J C Ilardo; A A Valda; M E Debray; H R Somacal; J C Suarez Sandin; M Igarzabal; H Huck; L Estrada; M Repetto; M Obligado; J Padulo; D M Minsky; M Herrera; S J Gonzalez; M E Capoulat
Journal:  Appl Radiat Isot       Date:  2011-02-15       Impact factor: 1.513

4.  Towards the final BSA modeling for the accelerator-driven BNCT facility at INFN LNL.

Authors:  C Ceballos; J Esposito; S Agosteo; P Colautti; V Conte; D Moro; A Pola
Journal:  Appl Radiat Isot       Date:  2011-02-01       Impact factor: 1.513

5.  AB-BNCT beam shaping assembly based on 7Li(p,n)7Be reaction optimization.

Authors:  D M Minsky; A J Kreiner; A A Valda
Journal:  Appl Radiat Isot       Date:  2011-03-15       Impact factor: 1.513

6.  Experimental verification of beam characteristics for cyclotron-based epithermal neutron source (C-BENS).

Authors:  H Tanaka; Y Sakurai; M Suzuki; S Masunaga; T Mitsumoto; K Fujita; G Kashino; Y Kinashi; Y Liu; M Takada; K Ono; A Maruhashi
Journal:  Appl Radiat Isot       Date:  2011-03-21       Impact factor: 1.513

7.  New technical solution for using the time-of-flight technique to measure neutron spectra.

Authors:  V Aleynik; B Bayanov; A Burdakov; A Makarov; S Sinitskiy; S Taskaev
Journal:  Appl Radiat Isot       Date:  2011-02-15       Impact factor: 1.513

8.  Development of liquid-lithium film jet-flow for the target of (7)Li(p,n)(7)Be reactions for BNCT.

Authors:  Tooru Kobayashi; Kuniaki Miura; Noriyosu Hayashizaki; Masanori Aritomi
Journal:  Appl Radiat Isot       Date:  2013-12-19       Impact factor: 1.513

9.  Computational assessment of deep-seated tumor treatment capability of the 9Be(d,n)10B reaction for accelerator-based boron neutron capture therapy (AB-BNCT).

Authors:  M E Capoulat; D M Minsky; A J Kreiner
Journal:  Phys Med       Date:  2013-07-21       Impact factor: 2.685

10.  High-power liquid-lithium target prototype for accelerator-based boron neutron capture therapy.

Authors:  S Halfon; M Paul; A Arenshtam; D Berkovits; M Bisyakoev; I Eliyahu; G Feinberg; N Hazenshprung; D Kijel; A Nagler; I Silverman
Journal:  Appl Radiat Isot       Date:  2011-03-21       Impact factor: 1.513

View more
  19 in total

1.  Nuclear Theranostics in Taiwan.

Authors:  Ko-Han Lin; Yi-Wei Chen; Rheun-Chuan Lee; Ling-Wei Wang; Fong-In Chou; Chi-Wei Chang; Sang-Hue Yen; Wen-Sheng Huang
Journal:  Nucl Med Mol Imaging       Date:  2019-02-01

Review 2.  Physical, dosimetric and clinical aspects and delivery systems in neutron capture therapy.

Authors:  Bagher Farhood; Hadi Samadian; Mahdi Ghorbani; Seyed Salman Zakariaee; Courtney Knaup
Journal:  Rep Pract Oncol Radiother       Date:  2018-08-01

3.  Implications of radiation microdosimetry for accelerator-based boron neutron capture therapy: a radiobiological perspective.

Authors:  Hisanori Fukunaga; Yusuke Matsuya; Koichi Tokuuye; Motoko Omura
Journal:  Br J Radiol       Date:  2020-05-14       Impact factor: 3.039

4.  Microdosimetric quantities of an accelerator-based neutron source used for boron neutron capture therapy measured using a gas-filled proportional counter.

Authors:  Naonori Hu; Hiroki Tanaka; Takushi Takata; Keita Okazaki; Ryohei Uchida; Yoshinori Sakurai
Journal:  J Radiat Res       Date:  2020-03-23       Impact factor: 2.724

5.  Remarkable Boron Delivery Of iRGD-Modified Polymeric Nanoparticles For Boron Neutron Capture Therapy.

Authors:  Jiejian Chen; Qiyao Yang; Minchen Liu; Mengting Lin; Tiantian Wang; Zhentao Zhang; Xincheng Zhong; Ningning Guo; Yiying Lu; Jing Xu; Changsheng Wang; Min Han; Qichun Wei
Journal:  Int J Nanomedicine       Date:  2019-10-08

6.  Boron Neutron Capture Therapy: From Nuclear Physics to Biomedicine.

Authors:  Silva Bortolussi; Yuan-Hao Liu; Ignacio Porras
Journal:  Biology (Basel)       Date:  2021-04-26

7.  Radiobiological response of U251MG, CHO-K1 and V79 cell lines to accelerator-based boron neutron capture therapy.

Authors:  Eisuke Sato; Alexander Zaboronok; Tetsuya Yamamoto; Kei Nakai; Sergey Taskaev; Olga Volkova; Ludmila Mechetina; Alexander Taranin; Vladimir Kanygin; Tomonori Isobe; Bryan J Mathis; Akira Matsumura
Journal:  J Radiat Res       Date:  2018-03-01       Impact factor: 2.724

8.  Evaluation of a Novel Boron-Containing α-D-Mannopyranoside for BNCT.

Authors:  Takao Tsurubuchi; Makoto Shirakawa; Wataru Kurosawa; Kayo Matsumoto; Risa Ubagai; Hiroshi Umishio; Yasuyo Suga; Junko Yamazaki; Akihiro Arakawa; Yutaka Maruyama; Takuya Seki; Yusuke Shibui; Fumiyo Yoshida; Alexander Zaboronok; Minoru Suzuki; Yoshinori Sakurai; Hiroki Tanaka; Kei Nakai; Eiichi Ishikawa; Akira Matsumura
Journal:  Cells       Date:  2020-05-21       Impact factor: 6.600

9.  Opportunistic dose amplification for proton and carbon ion therapy via capture of internally generated thermal neutrons.

Authors:  Mitra Safavi-Naeini; Andrew Chacon; Susanna Guatelli; Daniel R Franklin; Keith Bambery; Marie-Claude Gregoire; Anatoly Rosenfeld
Journal:  Sci Rep       Date:  2018-11-02       Impact factor: 4.379

Review 10.  Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies.

Authors:  Paul Hoppenz; Sylvia Els-Heindl; Annette G Beck-Sickinger
Journal:  Front Chem       Date:  2020-07-07       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.